BioCryst Pharmaceuticals (BCRX) to Present Three Posters on BCX4208 as Gout Treatment
Go back to BioCryst Pharmaceuticals (BCRX) to Present Three Posters on BCX4208 as Gout Treatment| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.70 -0.24 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.94 | 52 Week High | $10.98 | |||
| Open | $9.89 | 52 Week Low | $1.63 | |||
| Day High | $9.94 | P/E | N/A | |||
| Day Low | $9.55 | EPS | $-0.68 | |||
| Volume | 2,122,103 | |||||
